The Effect of Breastfeeding Support Provided Via Video-conferencing
15 juni 2021 uppdaterad av: Deniz Akyıldız, Kahramanmaras Sutcu Imam University
The Effect of Breastfeeding Support Provided Via Video-conferencing on Postpartum Anxiety, Breastfeeding Self-Efficacy and Neonatal Outcomes: A Randomized Controlled Trial
A randomized control trial was made to examine the effects of breastfeeding support given by the video-conferencing method in the early postpartum period on anxiety, breastfeeding self-efficiency, and newborn outcomes.
Studieöversikt
Status
Rekrytering
Betingelser
Intervention / Behandling
Studietyp
Interventionell
Inskrivning (Förväntat)
78
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studiekontakt
- Namn: Deniz Akyıldız, PhD
- Telefonnummer: 05069851358
- E-post: denizbtm@gmail.com
Studera Kontakt Backup
- Namn: Deniz Akyıldız
- Telefonnummer: 05069851358
- E-post: denizbtm@gmail.com
Studieorter
-
-
Kahramanmaraş
-
Kahramanmaras, Kahramanmaraş, Kalkon, 4600
- Rekrytering
- Kahramanmaras Sutcu Imam University
-
Kontakt:
- Deniz Akyıldız
- Telefonnummer: 05069851358
- E-post: denizbtm@gmail.com
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
19 år och äldre (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Ja
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
Infants;
- Born between 37 and 42 weeks
- Without severe congenital anomalies
Mothers;
- A single live birth
- Were 18 years of age or over
- At least primary school graduate
- Did not have a disease that prevents breastfeeding
- Had internet access at home or on the phone
- Could speak and understand the Turkish language.
Exclusion Criteria:
- Situations that cause separation of mother and baby
- Hospitalization of the baby in intensive care
- Inability to answer 3 calls in a video call
- They were determined as those who could not be reached during the home visit for the first and second follow
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Video-conferencing group
The mothers in the video-conferencing group were counseled via video-conferencing a total of six times (three times a week, at equal intervals) during the first 2 weeks after birth.
Each interview was approximately 15-20 minutes.
In video-conferencing sessions, the breastfeeding position, the mother's grasping the breast, the baby's latch-on, and sucking duration were observed.
Mothers' questions were answered and solutions were offered for breastfeeding problems (sore nipple, engorgement, etc.).
|
No intervention
Andra namn:
|
|
Inget ingripande: Control group
The mothers in the control group were given usual care before discharge and no intervention was made after discharge.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
The mean postpartum maternal anxiety level (mean ± SD)
Tidsram: at 2 weeks and 4 weeks after delivery
|
The primary outcome of this study was the mean postpartum maternal anxiety level (mean ± SD) of the mothers at 2 weeks and 4 weeks after delivery.
Maternal anxiety level was assessed using the Postpartum Specific Anxiety Scale.
The scale comprises 51 items and 4 sub-dimensions.
It means that those who score 73 and below on the scale have low postpartum anxiety levels, those who score between 74 and 100 have a medium level, and those who score 101 and above have a high level of anxiety.
|
at 2 weeks and 4 weeks after delivery
|
|
The mean breastfeeding self-efficacy level
Tidsram: at 2 weeks and 4 weeks after delivery
|
The other main outcome of the study was the mean breastfeeding self-efficacy level (mean ± SD) measured with the Breastfeeding Self-Efficacy Scale Short Form.
The scale is likert type and a total score between 14 and 70 is taken from the scale.
The higher the score, the higher the breastfeeding self-efficacy.
|
at 2 weeks and 4 weeks after delivery
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Neonatal outcomes-Newborn weight (g)
Tidsram: at 2 weeks and 4 weeks after delivery
|
Newborn weight (g) was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery
|
at 2 weeks and 4 weeks after delivery
|
|
Neonatal outcomes-Hypoglycemia of the newborn
Tidsram: at 2 weeks and 4 weeks after delivery
|
Hypoglycemia of the newborn was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery.
|
at 2 weeks and 4 weeks after delivery
|
|
Neonatal outcomes-Need for phototherapy
Tidsram: at 2 weeks and 4 weeks after delivery
|
The need for phototherapy was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery
|
at 2 weeks and 4 weeks after delivery
|
|
Neonatal outcomes-Respiratory morbidity
Tidsram: at 2 weeks and 4 weeks after delivery
|
Respiratory morbidity was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery
|
at 2 weeks and 4 weeks after delivery
|
|
Neonatal outcomes-illness requiring hospitalization
Tidsram: at 2 weeks and 4 weeks after delivery
|
Illness requiring hospitalization was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery
|
at 2 weeks and 4 weeks after delivery
|
|
Neonatal outcomes-Food intake other than breast milk
Tidsram: at 2 weeks and 4 weeks after delivery
|
Food intake other than breast milk was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery
|
at 2 weeks and 4 weeks after delivery
|
|
Neonatal outcomes-Neonatal death
Tidsram: at 2 weeks and 4 weeks after delivery
|
Neonatal death was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery
|
at 2 weeks and 4 weeks after delivery
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Utredare
- Huvudutredare: Betül Bay, Kahramanmaras Sutcu Imam University
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Faktisk)
25 augusti 2020
Primärt slutförande (Förväntat)
30 september 2021
Avslutad studie (Förväntat)
30 september 2021
Studieregistreringsdatum
Först inskickad
7 juni 2021
Först inskickad som uppfyllde QC-kriterierna
15 juni 2021
Första postat (Faktisk)
18 juni 2021
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
18 juni 2021
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
15 juni 2021
Senast verifierad
1 juni 2021
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- Breastfeeding Support
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
NEJ
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .